2023 international evidence-based guideline pcos glp-1 receptor agonist Research progress on insulin resistance in polycystic ovary syndrome Recommendations From the 2023 International
Description
Find more detailed side effect and risk information for specific medications by name here
doi: 10.1677/joe.0.1740233 117 DruckerDJPhilippeJMojsovSChickWLHabenerJF
These agents mimic the bodys natural glucagon-like peptide-1 hormone, regulating blood glucose while promoting satiety and weight loss
It should be mentioned that in the Liraglutide Effect and Action in Diabetes (LEAD)-6 trial (duration 26 weeks) no difference was observed in estimated geometric mean calcitonin levels between liraglutide 1.8 mg once daily and exenatide 10 g twice daily [31]
